SAN DIEGO, Dec. 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® Japan had its best revenue month in the Company’s history in November 2021.
“We’ve experienced tremendous growth and success in Japan this quarter,” said Kannaway® CEO Blake Schroeder. “We are excited about our continued development throughout Asia-Pacific as we continue to expand our presence throughout the region.”
According to Research and Markets, the global cannabidiol (CBD) oil market is expected to reach $5.3 billion by 2025 with Asia-Pacific as one of the fastest-growing regions.
“The popularity of CBD products in Japan is growing rapidly and we have been able to help further this trend by connecting with consumers to help them become educated on what CBD is and what high-quality CBD products are best for them,” said Kannaway® Global Sales Officer Peter Dale. “We are proud to be the market leaders in the CBD category in Japan and around the world.”
